Assessing the Danger of Neuraminidase Inhibitor Resistance in Influenza
Author Information
Author(s): Andreas Handel, Ira M. Longini Jr., Rustom Antia
Primary Institution: Emory University
Hypothesis
How likely is it that an infected patient can generate a resistant infection in a secondary host, and how likely is it that the resistant strain subsequently spreads?
Conclusion
The initial generation of resistant cases is likely lower than previously reported, but the spread of resistance is influenced by the immune response and treatment timing.
Supporting Evidence
- Neuraminidase inhibitors are the most effective drugs against influenza.
- The study provides estimates for parameters that can be used in models to study resistance emergence.
- Early treatment can reduce the generation of resistant strains.
Takeaway
This study looks at how resistant strains of the flu virus can spread and how treatment affects this. It finds that early treatment can help prevent resistance.
Methodology
The study combines data from human influenza infections with mathematical models to estimate parameters for resistance generation and spread.
Potential Biases
The models used may not accurately reflect the complexities of immune responses and viral dynamics.
Limitations
The study's results depend on estimates that come with significant uncertainty, particularly regarding within-host dynamics and the conversion rate between TCID50 and virions.
Participant Demographics
Data from human volunteers infected with influenza.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website